Aegerion Files Ch. 11, Plans $400M Sale To Amryt Pharma - Law360
05/21/19
Aegerion Files Ch. 11, Plans $400M Sale To Amryt Pharma Law360
Embattled specialty drug company Aegerion has filed for bankruptcy with plans to sell itself to Amryt Pharma PLC for $400 million, a move that comes one year ...
[more]